Principles and problems of transfusion in sickle cell disease

Area of Science:

• Hematology
• Transfusion Medicine
• Genetic Blood Disorders

Background:

• Sickle cell disease (SCD) involves red blood cell (RBC) abnormalities and anemia, making blood transfusions a primary treatment.
• Transfusion therapy in SCD presents distinct and significant adverse effects that require careful consideration.
• Despite extensive research, knowledge gaps and controversies persist regarding optimal transfusion practices for SCD patients.

Purpose of the Study:

• To review the indications, goals, and potential adverse effects of blood transfusion therapy in sickle cell disease.
• To highlight ongoing challenges and areas of controversy in SCD transfusion management.
• To underscore the critical need for defined clinical management strategies for severe transfusion complications.

Main Methods:

• Review of clinical observations and published studies on transfusion therapy in SCD.
• Analysis of existing literature on adverse effects and serologic barriers.
• Discussion of persistent complications and management challenges.

Main Results:

• Blood transfusion is essential for managing anemia and complications in SCD.
• Transfusion therapy is associated with unique and serious adverse effects in SCD patients.
• Serologic barriers and hyperhemolysis remain significant challenges in optimizing SCD transfusion therapy.

Conclusions:

• Optimizing transfusion therapy for sickle cell disease requires a thorough understanding of its benefits and risks.
• Further research is needed to address serologic barriers and manage life-threatening complications like hyperhemolysis.
• Clearer clinical guidelines are essential for the safe and effective management of blood transfusions in SCD.